ID
40843
Description
Study ID: 103933 Clinical Study ID: NKV103933 Study Title: A non-randomised, open label, two period cross-over study to determine the excretion balance and metabolic disposition of [14C]-GW679769, administered as single doses of an oral solution and an intravenous infusion to healthy male subjects Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier:N/A Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: casopitant Trade Name: Rezonic,Zunrisa; Zunrisa,Rezonic Study Indication: Nausea and Vomiting, Chemotherapy-Induced Protocol ID: NKV103933 The eligibility to participate was determined during a screening visit within 21 days prior to first dosing day. The study consisted of two dosing periods, each consisting of predose visit, monitoring after dose administration and prior to discharge visit. Dosing periods were separated by a wash-out period of 43 days. The Concomitant Medications has to be filled in at the Screening Visit and throughout the study whenever a change in patient's medication is made.
Mots-clés
Versions (1)
- 24/05/2020 24/05/2020 -
Détendeur de droits
GlaxoSmithKline
Téléchargé le
24 mai 2020
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Study of Casopitant Pharmacokinetics in Healthy Males, NKV103933
Concomitant Medications
- StudyEvent: ODM
Description
Concomintant Medications
Alias
- UMLS CUI-1
- C2347852
Description
If Yes, record each medication on a separate line using Trade Names where possible. If the medication is related to a Non-Serious Adverse Event or Serious Adverse Event, details should be expressed using the same terminology.
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0347984
- UMLS CUI [1,3]
- C0008976
Description
List of Concomintant Medications
Alias
- UMLS CUI-1
- C2347852
Description
Concomitant Agent Drug Name
Type de données
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C2360065
Description
Concomitant Agent Unit Dose
Type de données
float
Alias
- UMLS CUI [1]
- C2826646
Description
Concomitant Agent Unit
Type de données
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0439148
Description
Concomitant Agent Frequency
Type de données
text
Alias
- UMLS CUI [1]
- C2826654
Description
Concomitant Agent Drug Administration Routes
Type de données
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C0013153
Description
Concomitant Agent Indication
Type de données
text
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C3146298
Description
Concomitant Agent Start Date
Type de données
date
Alias
- UMLS CUI [1]
- C2826734
Description
Concomitant Agent Start Time
Type de données
time
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1301880
Description
Concomitant Agent Taken Prior to Study?
Type de données
boolean
Alias
- UMLS CUI [1]
- C2826667
Description
Concomitant Agent Stop Date
Type de données
date
Alias
- UMLS CUI [1]
- C2826744
Description
Concomitant Agent Stop Time
Type de données
time
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C1522314
Description
Concomitant Agent Ongoing
Type de données
boolean
Alias
- UMLS CUI [1]
- C2826666
Similar models
Concomitant Medications
- StudyEvent: ODM
C0347984 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C2360065 (UMLS CUI [1,2])
C0439148 (UMLS CUI [1,2])
C0013153 (UMLS CUI [1,2])
C3146298 (UMLS CUI [1,2])
C1301880 (UMLS CUI [1,2])
C1522314 (UMLS CUI [1,2])